Page last updated: 2024-10-30

lofepramine and Diabetic Neuropathies

lofepramine has been researched along with Diabetic Neuropathies in 1 studies

Lofepramine: A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Worsley, AP1
Allawi, J1

Other Studies

1 other study available for lofepramine and Diabetic Neuropathies

ArticleYear
A combined treatment for severe diabetic neuropathy symptoms.
    Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:9

    Topics: Adult; Antidepressive Agents, Tricyclic; Diabetic Neuropathies; Drug Therapy, Combination; Hematinic

1998